These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 15630525)
1. Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children. Shao L; Hill DA; Perlman EJ Pediatr Dev Pathol; 2004; 7(6):577-82. PubMed ID: 15630525 [TBL] [Abstract][Full Text] [Related]
2. Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour. Portugal R; Barroca H Cytopathology; 2008 Apr; 19(2):80-5. PubMed ID: 17681013 [TBL] [Abstract][Full Text] [Related]
3. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515 [TBL] [Abstract][Full Text] [Related]
4. Fine-needle aspiration cytology of clear-cell sarcoma of the kidney: study of eight cases. Iyer VK; Agarwala S; Verma K Diagn Cytopathol; 2005 Aug; 33(2):83-9. PubMed ID: 16007650 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Ellison DA; Parham DM; Bridge J; Beckwith JB Hum Pathol; 2007 Feb; 38(2):205-11. PubMed ID: 17134738 [TBL] [Abstract][Full Text] [Related]
6. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features. Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746 [TBL] [Abstract][Full Text] [Related]
8. Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the Kidney. Jet Aw S; Hong Kuick C; Hwee Yong M; Wen Quan Lian D; Wang S; Liang Loh AH; Ling S; Lian Peh G; Yen Soh S; Pheng Loh AH; Hoon Tan P; Tou En Chang K Pediatr Dev Pathol; 2015; 18(4):297-304. PubMed ID: 25751590 [TBL] [Abstract][Full Text] [Related]
9. [New aspects of nephroblastoma (Wilms tumor) and other metanephrogenic neoplasms]. Harms D; Schmidt D; Leuschner I Verh Dtsch Ges Pathol; 1989; 73():350-71. PubMed ID: 2482620 [TBL] [Abstract][Full Text] [Related]
10. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis. Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773 [TBL] [Abstract][Full Text] [Related]
11. Role of Cyclin D1 and BCOR Immunohistochemistry in Differentiating Clear Cell Sarcoma of Kidney From its Mimics. Singh V; Gupta K; Saraswati A; Peters NJ; Trehan A J Pediatr Hematol Oncol; 2021 Nov; 43(8):294-300. PubMed ID: 34673711 [TBL] [Abstract][Full Text] [Related]
12. The cytological diagnosis of paediatric renal tumours. Shet T; Viswanathan S J Clin Pathol; 2009 Nov; 62(11):961-9. PubMed ID: 19700411 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor. Sehic D; Ciornei CD; Gisselsson D Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327 [TBL] [Abstract][Full Text] [Related]
14. Multifaceted dysregulation of the epidermal growth factor receptor pathway in clear cell sarcoma of the kidney. Little SE; Bax DA; Rodriguez-Pinilla M; Natrajan R; Messahel B; Pritchard-Jones K; Vujanic GM; Reis-Filho JS; Jones C Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4360-4. PubMed ID: 17646270 [TBL] [Abstract][Full Text] [Related]
15. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Cutcliffe C; Kersey D; Huang CC; Zeng Y; Walterhouse D; Perlman EJ; Clin Cancer Res; 2005 Nov; 11(22):7986-94. PubMed ID: 16299227 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications. Sugimura J; Yang XJ; Tretiakova MS; Takahashi M; Kort EJ; Fulton B; Fujioka T; Vogelzang NJ; Teh BT Urology; 2004 Aug; 64(2):362-8; discussion 368. PubMed ID: 15302496 [TBL] [Abstract][Full Text] [Related]
17. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature. Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Zhao C; Bratthauer GL; Barner R; Vang R Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194 [TBL] [Abstract][Full Text] [Related]
19. Functional and gene expression analysis of the p53 signaling pathway in clear cell sarcoma of the kidney and congenital mesoblastic nephroma. Brownlee NA; Hazen-Martin DJ; Garvin AJ; Re GG Pediatr Dev Pathol; 2002; 5(3):257-68. PubMed ID: 12007018 [TBL] [Abstract][Full Text] [Related]
20. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children. Miniati D; Gay AN; Parks KV; Naik-Mathuria BJ; Hicks J; Nuchtern JG; Cass DL; Olutoye OO J Pediatr Surg; 2008 Jul; 43(7):1301-7. PubMed ID: 18639686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]